XML 34 R6.htm IDEA: XBRL DOCUMENT v2.4.0.8
Consolidated Statements of Cash Flows (USD $)
 6 Months Ended 12 Months Ended
Jun. 30, 2014
Dec. 31, 2013
Dec. 31, 2012
Cash flows from operating activities      
Net loss $ (21,335,988) $ (19,871,908) $ (6,860,030)
Adjustments to reconcile net loss to net cash used in operating activities:      
Depreciation expense 2,330 373   
Common stock issued for services 8,714 3,766,918 1,330,849
Stock-based compensation 10,319,137 382,343 37,335
Amortization of debt discount 327,776 118,639   
Amortization of deferred financing costs 78,724 69,546   
Loss on change in fair value of derivative liabilities 7,954,970 12,877,675 3,688,353
Changes in operating assets and liabilities:      
Prepaid expenses and other assets (89,983) 160,283 (182,708)
Accounts payable 565,779 (57,102) 32,299
Accrued expenses 4,287 315,704 369,927
Net cash used in operating activities (2,164,254) (2,237,529) (1,583,975)
Cash flows from investing activities      
Purchase of fixed assets (3,673) (8,871)   
Net cash used in investing activities (3,673) (8,871)   
Cash flows from financing activities      
Proceeds from sale of Series A preferred stock and warrants    3,494,428 3,220,018
Proceeds from sale of common stock and warrants 22,229,321      
Proceeds from sales of common and Class A Series A preferred stock, pursuant to Share Exchange 2,000,000      
Payment of notes payable (19,493)    (39,990)
Proceeds from subordinated promissory notes payable, net of financing costs    501,600 154,900
Net cash provided by financing activities 24,209,828 3,996,028 3,334,928
Net increase in cash 22,041,901 1,749,628 1,750,953
Cash at beginning of the period 3,522,450 1,772,822 21,869
Cash at end of the period 25,564,351 3,522,450 1,772,822
Cash paid during the period for:      
Income taxes         
Interest 1,103      
Non-cash investing and financing transactions:      
Conversion of Series A Preferred Stock and Subordinated Notes to common stock 900,000      
Conversion of accrued interest to common stock 60,922      
Note payable issued in connection with director and officer insurance policy 77,850     
Fair value of derivative reclassified to additional paid-in-capital in connection with Share Exchange 6,804,625      
Fair value of warrant derivatives issued with units offering 4,333,163      
Beneficial conversion feature 186,727      
Fair value of derivatives issued in connection with issuance of preferred stock    1,761,063 984,465
Fair value of derivative warrants issued to lenders in connection with issuance of subordinated promissory notes    83,363 26,325
Fair value of warrants issued in connection with deferred financing costs    41,681 13,089
Fair value of derivative warrants issued for offering costs in connection with the issuance of Series A preferred stock    248,655 79,615
Fair value of derivative issued to Wonpung for services       299,141
Exchange of loans and accrued interest for common stock from founder       1,222,321
Exchange of subordinated notes and accrued interest for Series A preferred stock       1,541,180
Cashless exercise of warrants for common stock       $ 54,143